Science communication in transition: Genomics hype, public engagement, education and commercialization pressures

Clinical Genetics

Volumn 70, Issue 5, 2006, Pages 445-450

  Bubela, Tania ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Commercialization; Genomics; Media; Public engagement; Public opinion; Public trust; Science communication; Science education

Indexed keywords

ARTICLE; CANADA; CLINICAL STUDY; COMMERCIAL PHENOMENA; FUNDING; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOMICS; GENOTYPE PHENOTYPE CORRELATION; HEALTH CARE ORGANIZATION; HUMAN; HUMAN GENOME PROJECT; HUMANITIES; INDUSTRY; INFORMATION PROCESSING; MASS COMMUNICATION; MEDICAL EDUCATION; MEDICAL RESEARCH; PHENOTYPE; POLITICS; PRIORITY JOURNAL; PROFESSIONAL DEVELOPMENT; PUBLIC HEALTH SERVICE; SCIENCE; SCIENTIST; SOCIOLOGY; TEACHER; WORKSHOP;

COMMERCE; COMMUNICATION; GENETICS, MEDICAL; GENOMICS; HUMANS; MASS MEDIA; PUBLIC OPINION;

PHLEUM PRATENSE;

EID: 33749475455     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2006.00693.x     Document Type: Article

References (21)

1. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004: 431: 931-945.
2. Ransohoff D, Ransohoff R. Sensationalism in the media: When scientists and journalists may be complicit collaborators. Eff Clin Pract 2001: 4: 185-188.
3. Caulfield T. The commercialization of medical and scientific reporting. PLoS Med 2004: 1: e38-e39.
4. Bubela T, Caulfield T. Do the print media "hype"genetic research? A comparison of newspaper stories and peer-reviewed research papers. CMAJ 2004: 170: 1399-1407.
5. Holtzman NA, Bernhardt BA, Mountcastle-Shah E, Rodgers JE, Tambor E, Geller G. The quality of media reports on discoveries related to human genetic diseases. Comm Genet 2005: 8: 133-144.
6. Condit C. What is 'public opinion' about genetics? Nat Rev Genet 2001: 2: 811-815.
7. Conrad P, Markens S. Constructing the 'Gay Gene' in the News: Optimism and Skepticism in the US and British Press. Health: 2001: 5: 373.
8. Petersen A. The Portrayal of Research into Genetic-Based Differences of Sex and Sexual Orientation: A Study of "Popular"Science Journals, 1980 to 1997. J Commun Inq 1999: 23: 163.
9. Marteau TM, Lerman C. Genetic risk and behavioural change. BMJ: 2001: 22: 1056-1059.
10. Bubela T, Caulfield T. When human dignity is not enough: Embryonic stem cell research and human cloning in Canada. In: Einsiedel EF, ed. Emerging technologies: Hindsight and foresight. Vancouver: UBC Press (in press).
11. Davey-Smith G, Ebrahim S. 'Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003: 32: 1-22.
12. Lewis S, Davey Smith G. Alcohol, ALDH2 and esophageal cancer: A meta-analysis which illustrates the potentials and limitations of a mendelian randomization approach. Cancer Epidemiol Biomarkers Prev 2005: 14: 1967-1971.
13. Gaskell G, Allum N, Bauer M et al. Biotechnology and the European public. Nat Biotechnol 2000: 18: 935-938.
14. Guston DH. Forget politicizing science. Let's democratize science! Issues Sci Technol. 2004: Fall: 25-28.
15. Guston DH, Sarewitz D. Real-time technology assessment. Technol Soc 2002: 24: 93-109.
16. House of Lords, Science and Technology Select Committee, 2001.
17. Kuhn TS. The structure of scientific revolutions, 3rd edn. Chicago: University Of Chicago Press, 1996.
18. Malinowski MJ, Littlefield N. Transformation of a research platform into commercial products. In: Caulfield T, Williams-Jones B, eds. The commercialization of genetic research: Ethical, legal, and policy issues. New York: Kluwer Academic/Plenum Publishers, 1999: 29-53.
19. Bozeman B. Technology transfer and public policy: A review of research and theory. Res Policy 2000: 29: 627-655.
20. Canadian Biotechnology Secretariat, International Public Opinion Research on Emerging Technologies: Canada-U.S. Survey Results (Ottawa: Canadian Biotechnology Secretariat Industry Canada, March 2005). http://www.biostrategy.gc.ca/CMFiles/E-POR-ET_200549QZS-5202005-3081.pdf
21. Pollara and Earnscliffe Research and Communications. "Third Wave: Executive Summary (Prepared for and presented to the Biotechnology Assistant Deputy Minister Coordinating Committee (BACC), Government of Canada)."BioPortal (December 2000). http://www.biostrategy.gc.ca/ english/view.asp?x=551&all=true